[HTML][HTML] Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea …

…, R Chadwick, MA Pittman, TG Quinnell - Sleep medicine …, 2016 - Elsevier
Obstructive sleep apnoea-hypopnoea (OSAH) causes excessive daytime sleepiness,
impairs quality-of-life, and increases cardiovascular disease and road traffic accident risks. …

Prodromal parkinsonism and neurodegenerative risk stratification in REM sleep behavior disorder

…, JC Klein, C Lo, G Dennis, O Bandmann, T Quinnell… - Sleep, 2017 - academic.oup.com
Objectives Rapid eye movement (REM) sleep behavior disorder (RBD) is the most specific
marker of prodromal alpha-synucleinopathies. We sought to delineate the baseline clinical …

Prolonged invasive ventilation following acute ventilatory failure in COPD: weaning results, survival, and the role of noninvasive ventilation

TG Quinnell, S Pilsworth, JM Shneerson, IE Smith - Chest, 2006 - Elsevier
Background Invasive ventilation for COPD has significant mortality, and weaning can be
difficult. At Papworth Hospital, we provide a specialist weaning service using noninvasive …

Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease

…, K Szewczyk-Krolikowski, RA Menke, T Quinnell… - Brain, 2016 - academic.oup.com
See Postuma (doi: 10.1093/aww131 ) for a scientific commentary on this article. Resting state
functional magnetic resonance imaging dysfunction within the basal ganglia network is a …

A crossover randomised controlled trial of oral mandibular advancement devices for obstructive sleep apnoea-hypopnoea (TOMADO)

TG Quinnell, M Bennett, J Jordan… - Thorax, 2014 - thorax.bmj.com
Rationale Mandibular advancement devices (MADs) are used to treat obstructive sleep
apnoea-hypopnoea syndrome (OSAHS) but evidence is lacking regarding their clinical and cost-…

Continuous positive airway pressure versus standard care for the treatment of people with mild obstructive sleep apnoea (MERGE): a multicentre, randomised …

…, NR Ward, BD Kent, T Quinnell… - The Lancet …, 2020 - thelancet.com
Background The evidence base for the treatment of mild obstructive sleep apnoea is limited
and definitions of disease severity vary. The MERGE trial investigated the clinical …

[HTML][HTML] Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep …

…, M Morrell, J Fox-Rushby, T Quinnell - Health Technology …, 2014 - ncbi.nlm.nih.gov
BACKGROUND Obstructive sleep apnoea-hypopnoea (OSAH) causes excessive daytime
sleepiness (EDS), impairs quality of life (QoL) and increases cardiovascular disease and road …

A randomised crossover trial comparing volume assured and pressure preset noninvasive ventilation in stable hypercapnic COPD

…, M Ali, A Gulati, MG Davies, TG Quinnell… - COPD: Journal of …, 2010 - Taylor & Francis
Recent randomised controlled trials suggest non-invasive ventilation may offer benefit in the
long-term management of ventilatory failure in stable COPD. The best mode of ventilation is …

[HTML][HTML] Volume assured versus pressure preset non-invasive ventilation for compensated ventilatory failure in COPD

NS Oscroft, R Chadwick, MG Davies, TG Quinnell… - Respiratory …, 2014 - Elsevier
Background The addition of domiciliary non-invasive ventilation (NIV) to standard therapy in
chronic obstructive pulmonary disease (COPD) patients with compensated ventilatory …

Visual short-term memory deficits in REM sleep behaviour disorder mirror those in Parkinson's disease

M Rolinski, N Zokaei, F Baig, K Giehl, T Quinnell… - Brain, 2016 - academic.oup.com
Individuals with REM sleep behaviour disorder are at significantly higher risk of developing
Parkinson’s disease. Here we examined visual short-term memory deficits—long associated …